Global Biosimilar Monoclonal Antibodies Market Research Report 2024(Status and Outlook)

Global Biosimilar Monoclonal Antibodies Market Research Report 2024(Status and Outlook)



Report Overview:

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.

Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.

The Global Biosimilar Monoclonal Antibodies Market Size was estimated at USD 1854.65 million in 2023 and is projected to reach USD 4518.67 million by 2029, exhibiting a CAGR of 16.00% during the forecast period.

This report provides a deep insight into the global Biosimilar Monoclonal Antibodies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilar Monoclonal Antibodies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilar Monoclonal Antibodies market in any manner.

Global Biosimilar Monoclonal Antibodies Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Celltrion

Pfizer (Hospira)

3SBIO

Novartis (Sandoz)

Dr Reddy’s

Celgen Biopharma

Cadila Healthcare

Hisun Pharma

Torrent Pharmaceuticals

Market Segmentation (by Type)

Infliximab

Rituximab

Trastuzumab

Adalimumab

Other

Market Segmentation (by Application)

Oncology

Autoimmune Disease

Other

Geographic SegmentationNorth America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
    • Key Benefits of This Market Research:
    Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Biosimilar Monoclonal Antibodies Market
  • Overview of the regional outlook of the Biosimilar Monoclonal Antibodies Market:
    • Key Reasons to Buy this Report:
    Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
    • Customization of the Report

      In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

      Note: this report may need to undergo a final check or review and this could take about 48 hours.

      Chapter Outline

      Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

      Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilar Monoclonal Antibodies Market and its likely evolution in the short to mid-term, and long term.

      Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

      Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

      Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

      Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

      Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

      Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

      Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

      Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

      Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

      Chapter 12 is the main points and conclusions of the report.

  • 1 Research Methodology and Statistical Scope
    1.1 Market Definition and Statistical Scope of Biosimilar Monoclonal Antibodies
    1.2 Key Market Segments
    1.2.1 Biosimilar Monoclonal Antibodies Segment by Type
    1.2.2 Biosimilar Monoclonal Antibodies Segment by Application
    1.3 Methodology & Sources of Information
    1.3.1 Research Methodology
    1.3.2 Research Process
    1.3.3 Market Breakdown and Data Triangulation
    1.3.4 Base Year
    1.3.5 Report Assumptions & Caveats
    2 Biosimilar Monoclonal Antibodies Market Overview
    2.1 Global Market Overview
    2.1.1 Global Biosimilar Monoclonal Antibodies Market Size (M USD) Estimates and Forecasts (2019-2030)
    2.1.2 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts (2019-2030)
    2.2 Market Segment Executive Summary
    2.3 Global Market Size by Region
    3 Biosimilar Monoclonal Antibodies Market Competitive Landscape
    3.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2019-2024)
    3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2019-2024)
    3.3 Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.4 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2019-2024)
    3.5 Manufacturers Biosimilar Monoclonal Antibodies Sales Sites, Area Served, Product Type
    3.6 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
    3.6.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
    3.6.2 Global 5 and 10 Largest Biosimilar Monoclonal Antibodies Players Market Share by Revenue
    3.6.3 Mergers & Acquisitions, Expansion
    4 Biosimilar Monoclonal Antibodies Industry Chain Analysis
    4.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis
    4.2 Market Overview of Key Raw Materials
    4.3 Midstream Market Analysis
    4.4 Downstream Customer Analysis
    5 The Development and Dynamics of Biosimilar Monoclonal Antibodies Market
    5.1 Key Development Trends
    5.2 Driving Factors
    5.3 Market Challenges
    5.4 Market Restraints
    5.5 Industry News
    5.5.1 New Product Developments
    5.5.2 Mergers & Acquisitions
    5.5.3 Expansions
    5.5.4 Collaboration/Supply Contracts
    5.6 Industry Policies
    6 Biosimilar Monoclonal Antibodies Market Segmentation by Type
    6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    6.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2019-2024)
    6.3 Global Biosimilar Monoclonal Antibodies Market Size Market Share by Type (2019-2024)
    6.4 Global Biosimilar Monoclonal Antibodies Price by Type (2019-2024)
    7 Biosimilar Monoclonal Antibodies Market Segmentation by Application
    7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    7.2 Global Biosimilar Monoclonal Antibodies Market Sales by Application (2019-2024)
    7.3 Global Biosimilar Monoclonal Antibodies Market Size (M USD) by Application (2019-2024)
    7.4 Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2019-2024)
    8 Biosimilar Monoclonal Antibodies Market Segmentation by Region
    8.1 Global Biosimilar Monoclonal Antibodies Sales by Region
    8.1.1 Global Biosimilar Monoclonal Antibodies Sales by Region
    8.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region
    8.2 North America
    8.2.1 North America Biosimilar Monoclonal Antibodies Sales by Country
    8.2.2 U.S.
    8.2.3 Canada
    8.2.4 Mexico
    8.3 Europe
    8.3.1 Europe Biosimilar Monoclonal Antibodies Sales by Country
    8.3.2 Germany
    8.3.3 France
    8.3.4 U.K.
    8.3.5 Italy
    8.3.6 Russia
    8.4 Asia Pacific
    8.4.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region
    8.4.2 China
    8.4.3 Japan
    8.4.4 South Korea
    8.4.5 India
    8.4.6 Southeast Asia
    8.5 South America
    8.5.1 South America Biosimilar Monoclonal Antibodies Sales by Country
    8.5.2 Brazil
    8.5.3 Argentina
    8.5.4 Columbia
    8.6 Middle East and Africa
    8.6.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Region
    8.6.2 Saudi Arabia
    8.6.3 UAE
    8.6.4 Egypt
    8.6.5 Nigeria
    8.6.6 South Africa
    9 Key Companies Profile
    9.1 Celltrion
    9.1.1 Celltrion Biosimilar Monoclonal Antibodies Basic Information
    9.1.2 Celltrion Biosimilar Monoclonal Antibodies Product Overview
    9.1.3 Celltrion Biosimilar Monoclonal Antibodies Product Market Performance
    9.1.4 Celltrion Business Overview
    9.1.5 Celltrion Biosimilar Monoclonal Antibodies SWOT Analysis
    9.1.6 Celltrion Recent Developments
    9.2 Pfizer (Hospira)
    9.2.1 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Basic Information
    9.2.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Overview
    9.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Market Performance
    9.2.4 Pfizer (Hospira) Business Overview
    9.2.5 Pfizer (Hospira) Biosimilar Monoclonal Antibodies SWOT Analysis
    9.2.6 Pfizer (Hospira) Recent Developments
    9.3 3SBIO
    9.3.1 3SBIO Biosimilar Monoclonal Antibodies Basic Information
    9.3.2 3SBIO Biosimilar Monoclonal Antibodies Product Overview
    9.3.3 3SBIO Biosimilar Monoclonal Antibodies Product Market Performance
    9.3.4 3SBIO Biosimilar Monoclonal Antibodies SWOT Analysis
    9.3.5 3SBIO Business Overview
    9.3.6 3SBIO Recent Developments
    9.4 Novartis (Sandoz)
    9.4.1 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Basic Information
    9.4.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Overview
    9.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Market Performance
    9.4.4 Novartis (Sandoz) Business Overview
    9.4.5 Novartis (Sandoz) Recent Developments
    9.5 Dr Reddy’s
    9.5.1 Dr Reddy’s Biosimilar Monoclonal Antibodies Basic Information
    9.5.2 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Overview
    9.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Market Performance
    9.5.4 Dr Reddy’s Business Overview
    9.5.5 Dr Reddy’s Recent Developments
    9.6 Celgen Biopharma
    9.6.1 Celgen Biopharma Biosimilar Monoclonal Antibodies Basic Information
    9.6.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Overview
    9.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Market Performance
    9.6.4 Celgen Biopharma Business Overview
    9.6.5 Celgen Biopharma Recent Developments
    9.7 Cadila Healthcare
    9.7.1 Cadila Healthcare Biosimilar Monoclonal Antibodies Basic Information
    9.7.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Overview
    9.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Market Performance
    9.7.4 Cadila Healthcare Business Overview
    9.7.5 Cadila Healthcare Recent Developments
    9.8 Hisun Pharma
    9.8.1 Hisun Pharma Biosimilar Monoclonal Antibodies Basic Information
    9.8.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Overview
    9.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Product Market Performance
    9.8.4 Hisun Pharma Business Overview
    9.8.5 Hisun Pharma Recent Developments
    9.9 Torrent Pharmaceuticals
    9.9.1 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Basic Information
    9.9.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Overview
    9.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Market Performance
    9.9.4 Torrent Pharmaceuticals Business Overview
    9.9.5 Torrent Pharmaceuticals Recent Developments
    10 Biosimilar Monoclonal Antibodies Market Forecast by Region
    10.1 Global Biosimilar Monoclonal Antibodies Market Size Forecast
    10.2 Global Biosimilar Monoclonal Antibodies Market Forecast by Region
    10.2.1 North America Market Size Forecast by Country
    10.2.2 Europe Biosimilar Monoclonal Antibodies Market Size Forecast by Country
    10.2.3 Asia Pacific Biosimilar Monoclonal Antibodies Market Size Forecast by Region
    10.2.4 South America Biosimilar Monoclonal Antibodies Market Size Forecast by Country
    10.2.5 Middle East and Africa Forecasted Consumption of Biosimilar Monoclonal Antibodies by Country
    11 Forecast Market by Type and by Application (2025-2030)
    11.1 Global Biosimilar Monoclonal Antibodies Market Forecast by Type (2025-2030)
    11.1.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Type (2025-2030)
    11.1.2 Global Biosimilar Monoclonal Antibodies Market Size Forecast by Type (2025-2030)
    11.1.3 Global Forecasted Price of Biosimilar Monoclonal Antibodies by Type (2025-2030)
    11.2 Global Biosimilar Monoclonal Antibodies Market Forecast by Application (2025-2030)
    11.2.1 Global Biosimilar Monoclonal Antibodies Sales (Kilotons) Forecast by Application
    11.2.2 Global Biosimilar Monoclonal Antibodies Market Size (M USD) Forecast by Application (2025-2030)
    12 Conclusion and Key Findings

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings